Public Offering Hunters

[starbuxsux]

$XON - XON Prices Offering At $27/Share

1/22/2015 3:46 AM ET

Intrexon Corp. (XON: Quote) is selling 3.75 million shares of its common stock to the public at a price of $27.00 each. The underwriters have a 30-day option to purchase up to an additional 562,500 shares of common stock offered in the public offering.

Last week, Intrexon and its oncology partner, ZIOPHARM Oncology (ZIOP) entered into a broad exclusive licensing agreement with The University of Texas MD Anderson Cancer Center for CAR T (chimeric antigen receptor T) Cell, TCR (T-cell receptor), NK (Natural killer) Cell programs and associated technologies for the development of non-viral adoptive cellular therapies. The company expects up to five CARs to enter the clinic in 2015.

Intrexon in partnership with Fibrocell Science Inc. (FCSC) is developing a cell-based therapeutic GM-HDF-COL7 for the treatment of recessive dystrophic epidermolysis bullosa (RDEB), the most severe form of the rare connective tissue disorder epidermolysis bullosa. The companies plan to file an investigational new drug application with the FDA in the first half of 2015 for GM-HDF-COL7.

The offering is expected to generate proceeds of approximately $101.25 million, and is scheduled to close on January 27, 2015.

XON closed Wednesday's trading at $28.40, down 12.32%.

by RTT Staff Writer

For comments and feedback: [e-mail]